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Abstract
Background: Pandemic influenza H1N1 (pdmH1N1) virus causes mild disease in humans but occasionally leads to
severe complications and even death, especially in those who are pregnant or have underlying disease. Cytokine
responses induced by pdmH1N1 viruses in vitro are comparable to other seasonal influenza viruses suggesting the
cytokine dysregulation as seen in H5N1 infection is not a feature of the pdmH1N1 virus. However a comprehensive
gene expression profile of pdmH1N1 in relevant primary human cells in vitro has not been reported. Type I alveolar
epithelial cells are a key target cell in pdmH1N1 pneumonia.
Methods: We carried out a comprehensive gene expression profiling using the Affymetrix microarray platform to
compare the transcriptomes of primary human alveolar type I-like alveolar epithelial cells infected with pdmH1N1
or seasonal H1N1 virus.
Results: Overall, we found that most of the genes that induced by the pdmH1N1 were similarly regulated in
response to seasonal H1N1 infection with respect to both trend and extent of gene expression. These commonly
responsive genes were largely related to the interferon (IFN) response. Expression of the type III IFN IL29 was more
prominent than the type I IFN IFNb and a similar pattern of expression of both IFN genes was seen in pdmH1N1
and seasonal H1N1 infection. Genes that were significantly down-regulated in response to seasonal H1N1 but not
in response to pdmH1N1 included the zinc finger proteins and small nucleolar RNAs. Gene Ontology (GO) and
pathway over-representation analysis suggested that these genes were associated with DNA binding and
transcription/translation related functions.
Conclusions: Both seasonal H1N1 and pdmH1N1 trigger similar host responses including IFN-based antiviral
responses and cytokine responses. Unlike the avian H5N1 virus, pdmH1N1 virus does not have an intrinsic capacity
for cytokine dysregulation. The differences between pdmH1N1 and seasonal H1N1 viruses lay in the ability of
seasonal H1N1 virus to down regulate zinc finger proteins and small nucleolar RNAs, which are possible viral
transcriptional suppressors and eukaryotic translation initiation factors respectively. These differences may be
biologically relevant and may represent better adaptation of seasonal H1N1 influenza virus to the host.
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Pandemic H1N1 remains a mild disease although occa-
sionally severe complications and death may ensue,
especially in those who are pregnant or have underlying
respiratory, cardiac or endocrine diseases or morbid
obesity [1]. We and others have demonstrated that
pdmH1N1 virus does not differ from seasonal influenza
viruses in its induction of cytokine responses in human
macrophages and epithelial cells [2-4]. This suggests
that the cytokine dysregulation seen in H5N1 infection
is not an intrinsic feature of the pdmH1N1 virus.
The pdmH1N1 virus arose from genetic reassortment
between influenza viruses endemic in swine, a North
American triple-reassortant swine influenza virus
acquiring a neuraminidase and matrix (M) gene segment
from viruses of the Eurasian-avian-like swine virus line-
age [5,6]. Since these swine viruses have in turn origi-
nated via complex genetic reassortments between swine,
avian and human influenza viruses, the pdmH1N1 virus
has a novel gene constellation with virus gene segments
that are derived from human (PB1), classical swine
H1N1 (HA, NP, NS), Eurasian avian-like swine (M, NA)
and avian (PB2, PA) sources. While the precursor swine
viruses were clearly well adapted to circulate in pigs for
periods ranging from 11 (North American triple reassor-
tant) to 90 (classical swine) years, evolutionary dating
analysis suggests that the pdmH1N1 virus transmitted
in humans only a few months prior to its detection in
March 2009 [6].
Using the Affymetrix microarray platform, we had
previously demonstrated that avian H5N1 viruses elicit
host responses that were qualitatively similar but quanti-
tatively markedly different to seasonal influenza H1N1
virus in human macrophages [7]. As the tracheo-bron-
chial epithelium, type I and II alveolar epithelial cells
and macrophages are key target cells for pdmH1N1
infection [8] and the most serious complication of
pdmH1N1 disease is primary viral pneumonia, we
employed type I-like alveolar epithelial cells as a model
to examine the host transcriptomes induced by
pdmH1N1 viruses compared with that of seasonal
H1N1 viruses using the same Affymetrix microarray
platform. We aimed to identify the mechanistic differ-
ences in host responses induced by these two H1N1
viruses, in order to provide insights into virus pathogen-
esis, which may in turn be relevant to therapeutic strate-
gies for the treatment of influenza.
Methods
Viruses
The viruses used were the pdmH1N1 2009 influenza A
virus (A/Hong Kong/415742/2009) and human seasonal
H1N1 influenza A virus (A/Hong Kong/54/1998). From
their initial isolation, the viruses were propagated in
Madin-Darby canine kidney (MDCK) cells. Virus infec-
tivity was determined by cytopathic assays on MDCK
cells and quantified as 50% tissue culture infectious dose
(TCID50). Infectious material was handled in a bio-safety
level 3 facility at the Department of Microbiology, The
University of Hong Kong.
Isolation of primary human alveolar type II alveolar
epithelial cells
Primary type II alveolar epithelial cells were isolated
using human non-malignant lung tissue as previously
described [3] obtained from patients undergoing lung
resection in the Department of Cardiothoracic Surgery,
Queen Mary Hospital, Hong Kong SAR, under a study
approved by the Institutional Review Board of the Uni-
v e r s i t yo fH o n gK o n ga n dH o s p i t a lA u t h o r i t yH o n g
Kong West Cluster. Written informed consent was pro-
vided by each patient. Briefly, after removing visible
bronchi, the lung tissue was minced into pieces of >0.5
mm thickness using a tissue chopper and washed with
balanced salt solution (BSS) containing Hanks’ balanced
salt solution (Gibco) with 0.7 mM sodium bicarbonate
(Gibco) at pH 7.4 for 3 times to partially remove macro-
phages and blood cells. The tissue was digested using a
combination of 0.5% trypsin (Gibco) and 4 U/ml elastase
(Worthington Biochemical Corporation, Lakewood, NJ,
USA) for 40 min at 37°C in a shaking water-bath. The
digestion was stopped by adding DMEM/F12 medium
(Gibco) with 40% FBS in and DNase I (350 U/ml)
(Sigma). Cell clumps were dispersed by repeatedly pipet-
ting the cell suspension for 10 min. A disposable cell
strainer (gauze size of 50 μm) (BD Science) was used to
separate large undigested tissue fragments. The single
cell suspension in the flow-through was centrifuged and
resuspended in a 1:1 mixture of DMEM/F12 medium
and small airway basal medium (SABM) (Lonza) supple-
mented with 0.5 ng/ml epidermal growth factor (hEGF),
500 ng/ml epinephrine, 10 μg/ml transferrin, 5 μg/ml
insulin, 0.1 ng/ml retinoic acid, 6.5 ng/ml triiodothyro-
nine, 0.5 μg/ml hydrocortisone, 30 μg/ml bovine pitui-
tary extract and 0.5 mg/ml BSA together with 5% FBS
and 350 U/ml DNase I. The cell suspension was plated
on plastic flask (Corning) and incubated in a 37°C
water-jacketed incubator with 5% CO2 supply for 90
min. The non-adherent cells were layered on a discon-
tinuous cold Percoll density gradient (densities 1.089
a n d1 . 0 4 0g / m l )a n dc e n t r i f u g e da t2 5 × g for 20 min
without brake. The cell layer at the interface of the two
gradients was collected and washed four times with BSS
to remove the Percoll. The cell suspension was incu-
bated with magnetic beads coated with anti-CD14 anti-
bodies at room temperature (RT) for 20 min under
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magnet (MACS CD14 MicroBeads), cell viability was
assessed by trypan-blue exclusion. The purified alveolar
epithelial cell suspension was resuspended in small air-
way growth medium (Lonza) supplemented with 1%
FBS, 100 U/ml penicillin and 100 μg/ml streptomycin,
and plated at a cell density of 3×10
5 cells/cm
2. The cells
were maintained in a humidified atmosphere (5% CO2,
37°C) under liquid-covered conditions, and growth med-
ium was changed daily starting from 60 h after plating
the cells.
Type I-like alveolar epithelial cell differentiation
The purified type II alveolar epithelial cell pellet (pas-
sage 1 or 2) was resuspended in medium to a final con-
centration that allowed seeding at 5 × 10
5 cells/cm
2
onto culture flask and cultured for 14 to 20 days with
the small airway culture medium SAGM (Lonza). The
cells spread to form a confluent monolayer and the cul-
ture medium was changed every 48 hbefore being used
for virus infection experiments.
Virus infection of type I-like alveolar epithelial cells
Type I-like alveolar epithelial cells were infected with
pdmH1N1 and seasonal H1N1 at a multiplicity of infec-
tion (MOI) of two. Minimum Essential Medium (MEM)
(Gibco) with 100 U/ml penicillin and 100 μg/ml strepto-
mycin was used as inoculum in the mock infected cells.
The cells were incubated with the virus inoculum for 1
h in a water-jacketed 37°C incubator with 5% CO2.
Then the cells were rinsed 3 times with warm PBS and
replenished with the appropriate growth medium. The
infected cells were harvested for mRNA collection at 8
h post-infection and viral M gene was quantified using
real-time PCR. Total RNA was extracted from cells after
8 h post-infection using the RNeasy Mini kit (Qiagen)
according to the manufacturer’s recommended protocol.
Microarray Analysis
Human gene expression was examined with the Gene-
Chip Human Gene 1.0 ST array (Affymetrix). The
Human Gene 1.0 ST array comprises more than 750,000
unique 25-mer oligonucleotide features, constituting
over 28,000 gene-level probe sets. RNA quality control,
sample labelling, GeneChip hybridization and data
acquisition were performed at the Genome Research
Centre, The University of Hong Kong. The quality of
total RNA was checked by the Agilent 2100 bioanalyzer.
The RNA was then amplified and labeled with Gene-
Chip® WT Sense Target Labeling and Control Reagents
kit (Affymetrix). cDNA was synthesized, labeled and
hybridized to the GeneChip array according to the man-
ufacturer’s protocol. The GeneChips were finally washed
and stained using the GeneChip Fluidics Station 450
(Affymetrix) and then scanned with the GeneChip Scan-
ner 3000 7G (Affymetrix).
GeneSpring GX 11 (Agilent) was used for the normali-
zation, filtering and statistical data analysis of the Affy-
metrix microarray data. The linear data was first
summarized using Exon Robust Multichip Average
(RMA) summarization algorithm on the CORE probe-
sets and Baseline Transformation to Median of all sam-
ples for three major tasks including Background
Correction, Normalization and Probe Summarization.
Briefly, Exon RMA performed a GC based background
correction followed by Quantile Normalization and sub-
sequently performed a Median Polish probe summariza-
tion. Next, quality control on samples was performed at
different levels including 1) internal controls to check
the RNA sample quality, 2) hybridization controls to
assess the hybridization quality and 3) Principal Compo-
nent Analysis (PCA) to check the data quality. Only
samples that found to be satisfactory in all quality con-
trol tests were included in further analysis. In the pro-
cess of data filtering, probesets with an intensity value
of the lowest 20th percentile of all the intensity values
were removed. The filtered entities resulted in a working
transcript list used for statistical analysis. An analysis of
variance (ANOVA) was performed to identify genes sig-
nificantly expressed (p < 0.05) in response to virus infec-
tion. In order to reduce the overall false positive hits,
Benjamini and Hochberg multiple testing correction was
employed. Significantly differentially expressed genes
with fold change ≥1.5 in response to pdmH1N1 and sea-
sonal H1N1 infection compared with mock were then
merged into a gene list for further GO and pathway
analysis.
GO and pathway over-representation analysis as well
as further analysis of protein-protein interactions and
transcription factor regulation were carried out using
the InnateDB platform [9,10]. Over-representation ana-
lyses were performed using a hypergeometric algorithm,
and over-represented GO terms or pathways with
p-values ≤ 0.05 were retained provided at least two
uploaded genes mapped to the entity in question. In
parallel, an independent pathway over-representation
analysis was also performed using the GeneSpring pro-
gram. Human pathway databases, including Integrating
Network Objects with Hierachies (INOH), Reactome,
Kyoto Encyclopedia Genes and Genomes (KEGG), Bio-
carta, National Cancer Institute (NCI) and NetPath,
were imported into the software for pathway analysis of
statistically significant genes.
Real-time quantitative RT-PCR assays
Total RNA was isolated using the RNeasy Mini kit (Qia-
gen) as described. The cDNA was synthesized from
mRNA with poly(dT) primers and Superscript III
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was monitored using a Power SYBR® Green PCR master
mix kit (Applied Biosystems) with corresponding pri-
mers. The fluorescence signals were measured using the
7500 real-time PCR system (Applied Biosystems). The
specificity of the SYBR® Green PCR signal was con-
firmed by melting curve analysis. The threshold cycle
(CT) was defined as the fractional cycle number at
which the fluorescence reached 10 times the standard
deviation of the base-line (from cycle 2 to 10). The ratio
change in target gene relative to the b-actin control
gene was determined by the 2
-ΔΔCT method as described
elsewhere [11].
Microarray data accession number
Microarray data has been deposited in the Gene Expres-
sion Omnibus (GEO) database [12] with the accession
number: GSE24533.
Results
We used the Affymetrix GeneChip Human Gene 1.0 ST
array to compare the global gene expression profiles of
human primary type I-like alveolar epithelial cells from
three independent donors (n = 3) after infection with
pdmH1N1, seasonal H1N1 viruses or mock control
infection at 8 h post-infection. Changes were observed
in 602 transcripts from 434 individual host genes (p <
0.05 in one-way ANOVA test).
I nap r e l i m i n a r ya n a l y s i s ,t h eg e n ee x p r e s s i o nd a t a
from each epithelial cell donor was analyzed separately
to define the donor-to-donor variation after influenza
infection. We used a ± 1.5-fold change in gene expres-
sion as the cut-off value and genes were classified into
those that were ≥ 1.5-fold up-regulated (+) or down-
regulated (-) relative to mock-infected cells and those
with no change in expression (fold change between -1.5
and +1.5).
Overall, 93.2% and 74.6% of genes were concordantly
expressed in the alveolar epithelial cells from the three
donors after infection with pdmH1N1 and seasonal
H1N1 virus respectively. The expression of those genes
with discordant results among donors was further ana-
lyzed. In 36 of 41 instances (87.8%) after pdmH1N1
infection and all instances after seasonal H1N1 infec-
tion, the apparently discordant genes had the same
trend of expression, being either up- or down-regulated
in all donors and the differences only reflected whether
the cut-off of ≥ 1.5-fold change in gene expression com-
pared to mock-infected cells was met. The remaining
five genes showed a contradictory regulation in cells
from different donors infected with pdmH1N1 virus.
These included C20orf94 (chromosome 20 open reading
frame 94), IPP (intracistemal A particle-promoted poly-
peptide), MRPL30 (mitochondrial ribosomal protein
L30), RTN4IP1 (reticulon 4 interacting Protein 1) and
SNORD44 (small nucleolar RNA, C/D box 44).
Given the high overall concordance in gene expression
profiles found among the three donors in our analysis,
the fold change of gene expression levels in response to
either the pdmH1N1 or seasonal H1N1 respectively,
compared to mock infection, was averaged across the
three donors for subsequent analysis. We filtered the
average gene-expression data using a cut-off value of
1.5-fold up- or down-regulation in the pdmH1N1- and
seasonal H1N1-infected cells compared to mock
infected cells. Compared to mock infected cells, 88
g e n e sw e r eu po rd o w n - r e g u l a t e di nr e s p o n s et os e a s o -
nal H1N1 infection while 18 genes were affected in
pdmH1N1 infected cells, all of them being up-regulated
(Figure 1A and Additional File 1: Summary of gene
expression in response to influenza A virus infection).
Sixteen of the 18 genes induced by the pdmH1N1
were similarly regulated in response to seasonal H1N1
infection with respect to both trend and extent of gene
expression (Figure 1B). Only two genes, basic leucine
zipper transcription factor, ATF-like 2 (BATF2)a n d
solute carrier family 15, member 3 (SLC15A3)w e r ed i f -
ferentially expressed in response to pdmH1N1 infection
only. On the other hand, there were 72 genes (68 genes
were down-regulated and 4 genes up-regulated) affected
in response to seasonal H1N1 but not in response to
pdmH1N1 infection when compared with the mock
infected cells (Figure 1B).
In order to compare the viral replication efficiency of
the two viruses, the expression level of viral M gene was
determined using real-time PCR (Figure 2). Although
t h e r ew a sat r e n dt oh i g h e rM gene copy numbers in
cells infected with seasonal H1N1 virus, the differences
were not statistically significant and comparable infec-
tious viral titres were detected in the cell supernatant by
viral titration. Genes of particular interest indentified in
the microarray analysis were verified using real time
quantitative PCR (Figures 2 and 3).
In order to investigate whether the trend towards higher
virus replication with seasonal H1N1 virus was responsible
for the difference in the gene expression we carried out an
experiment using MOI = 6. The M gene expression of the
two viruses was similar, but the differential expression of
ZBTB3, ZNF175, ZNF383, ZNF587 and ZNF8 genes with
expression in seasonal H1N1 infected cells being lower
than pdmH1N1 infected cells was maintained.
Over-representation analysis using InnateDB
To determine the biological relevance of the host gene
expression elicited by the two viruses and in particular
to identify any differences observed between these
viruses, we compared the over-represented GO terms
and biological pathways associated with the pdmH1N1-
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altered in response to seasonal H1N1. We used the
InnateDB analysis environment, and verified the results
of GO and pathway analyses using GeneSpring.
We observed that host responses induced by both
viruses were associated with ontological entities related
to innate immunity and responses to virus infections.
However, the genes expressed only in response to seaso-
nal influenza virus were associated with DNA binding
and transcription-related functions (Figure 4).
Pathway analysis returned a similar result, with genes
regulated in response to both viruses belonging to clas-
sical innate immune response pathways, while genes
regulated in response to seasonal H1N1 infection only
Figure 1 Summary of genes expressed in response to pdmH1N1 and seasonal H1N1 infection. (A) Genes that are significantly regulated
(p < 0.05 and fold change ≥1.5) in response to pdmH1N1 and seasonal H1N1 compared with mock infection at 8h post-infection are shown.
(B) Venn-diagram showing the genes that are differentially expressed in response to pdmH1N1 or seasonal H1N1 only and those that are co-
regulated by both viruses.
Figure 2 Validation of microarray data by real-time PCR. Expression of viral M gene and five ZNF genes were assessed after 8 h infection by
pdmH1N1 and seasonal H1N1 viruses compared to mock. Data shown was from three individual donors denoted as donor 1, 2 and 3.
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mRNA transport (Figure 5).
Comparison of the differentially expressed gene lists to
Interferome [13,14], an IFN-regulated gene database,
revealed that of the 16 genes up-regulated in response to
both seasonal and pandemic H1N1 infection, 15 of these
(93.75%) are related to the IFN response. A transcription
factor over-representation analysis was also performed using
InnateDB in order to identify transcription factors involved
in the regulation of seasonal-, pandemic- and shared-
response genes. Of the 13 transcription factors regulating
genes affected by both seasonal and pandemic viruses, four
(IRF1, IRF2, IRF7, IRF8) are known IFN response factors.
We also used InnateDB to compare the interactions
between genes differentially expressed in response to
either virus. Only a single difference was observed, with
the seasonal H1N1 response network distinguished by
the presence of the interacting DNA damage response-
related genes DNA-damage-inducible transcript 4
(DDIT4) and RAP1 interacting factor (RIF1), both of
which were down-regulated in response to seasonal
H1N1 but unchanged in response to pdmH1N1.
Discussion
Comparable IFN responses to pdmH1N1 and seasonal
H1N1 infection
In this study, we found that 16 out of 18 genes (88.9%)
induced by the pdmH1N1 virus were also similarly regu-
lated in response to seasonal H1N1 infection, and there
was no significant difference in expression level between
the two viruses.
Among these 16 genes, 15 were either IFNs or IFN-sti-
mulated genes and we found comparable up-regulation of
the type III IFNs, IL28A, IL28B and IL29 following seaso-
nal H1N1 or pdmH1N1 infection. Although type I and
type III IFNs bind to distinct receptors, they elicit similar
intracellular signals and gene expression profiles [15].
Figure 3 Validation of IFN gene expression by real-time PCR.
Expression of type I (IFNb) and type III (IL29) IFNs were assessed by
real-time PCR in pdmH1N1-, seasonal H1N1- and mock infected cells
at 8 h post-infection. The gene expression level averaged from the
three individual donors is shown.
Figure 4 Significantly enriched GO terms in response to seasonal and pandemic H1N1 infection.M F=m o l e c u l a rf u n c t i o n ,B P=
biological process, CC = cellular component. Only GO terms to which at least two differentially expressed genes were mapped are included.
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signal through a receptor complex consisting of IL10R2
and IFNlR1. Upon binding of IFNs, corresponding recep-
tor subunits dimerize to form the receptor complex and
activate the JAK-STAT signalling pathway, which then
results in downstream induction of genes such as ISGF3,a
trimetric transcription factor complex of signal transducer
and activator of transcription 1 and 2 (STAT1, STAT2)
and IFN regulatory factor 9 (IRF9). Downstream genes
regulated by this mechanism include genes reported to
have anti-viral activity such as IFN-stimulated gene 15
(ISG15) and myxovirus (influenza virus) resistance 1
(MX1) [16]. In this study, we found that IFN-related genes
including IL28A, IL28B, IL29, IRF9, ISG15 and MX1 were
significantly up-regulated in response to both pdmH1N1
and seasonal H1N1 infections and to a similar degree, sug-
gesting that similar host anti-viral mechanisms are trig-
gered in response to both H1N1 viruses.
In the microarray data, we were unable to detect the
expression of type I IFNs, such as IFNb,i nr e s p o n s et o
either pdmH1N1 or seasonal H1N1 infection. However,
we confirmed by real-time PCR the expression of IFNb
in response to both viruses, though present, it was nota-
bly lower when compared with type III IFN, IL29
(Figure 3). Similar patterns of expression of both IFN
genes were seen in pdmH1N1 and seasonal H1N1 infec-
tion. This is in agreement with our previous finding that
there was very low induction of type I IFNs in response
to pdmH1N1 or seasonal H1N1 in alveolar epithelial
cells and bronchial epithelial cells at 6 h post-infection
[3], which is probably related to the potent activity of
viral immune evasion genes such as NS1.O u rr e s u l t s
indicate that type III IFNs are likely to be particularly
important in host defence in both pdmH1N1 and seaso-
nal H1N1, possibly even more so than type I IFNs.
Lack of host translational control by small nucleolar RNA
in response to pdmH1N1 infection
When we examined genes expressed in response to sea-
sonal H1N1 influenza virus but not pdmH1N1 virus, we
noted a number of genes with roles in transcriptional or
translation control, including DNA binding and mRNA
transport. These genes were down-regulated in response to
infection with seasonal H1N1 influenza virus relative to
pdmH1N1. Several of these down-regulated genes are
small nucleolar RNAs. Previous studies have suggested that
host translational machinery is suppressed by the down-
regulation of small nucleolar RNAs, such as SNORA4,i n
cells following influenza A infection [17]. Here we observe
that SNORA4 is significantly down-regulated in response
to seasonal H1N1 infection but not in pdmH1N1 infected
cells, suggesting that seasonal H1N1 virus may be more
efficient at suppressing host translational mechanisms,
allowing for efficient translation of viral mRNA [18-20].
We also identified six small nucleolar RNAs that may
potentially act through a similar mechanism while the
functions of individual candidates in influenza pathogenesis
will require further investigation.
Lack of the control of transcriptional suppression by zinc
finger proteins in pdmH1N1 infected cells
We found that nine of the genes down-regulated
in response to seasonal H1N1 influenza virus (but not
pdmH1N1) encode zinc finger proteins, including
ZNF175. ZNF175 contains 13 zinc fingers and a KRAB
domain, for a motif known to be associated with
Figure 5 Significantly enriched pathways in response to seasonal and pandemic H1N1 infection. Only pathways to which at least two
differentially expressed genes were mapped are included.
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gested that zinc finger proteins are up-regulated in
response to HIV infection and that they inhibit production
of new virus through suppression of the HIV long terminal
repeat (LTR) promoter activity [21]. Further work demon-
strated that this suppression occurs via direct binding to
two distinct regulatory regions: the negative regulatory ele-
ment and the Ets element [22]. To date, no correlation
between zinc finger proteins and influenza virus has been
reported, however, we showed in this study that there was
a significant down-regulation of multiple zinc finger pro-
teins in response to seasonal H1N1 infection compared
with pdmH1N1. Further study will be important to inves-
tigate if there is an antiviral role of these zinc finger pro-
teins against influenza infection.
Comparison with Transcriptomic Data from Experimental
Animal Infection
Recently, a microarray analysis was reported characteriz-
ing host immune responses in ferret lung following
infection with the pdmH1N1 (A/California/07/2009)
and seasonal H1N1 (A/Brisbane/59/2007) [23]. In con-
cordance with our study, they observed that IFN
responses were triggered early after infection by both
H1N1 viruses. However, in contrast to our data, they
report that the range and magnitude of ISGs induced by
seasonal H1N1 was more limited compared to
p d m H 1 N 1 .H o w e v e r ,t h e s er e s u l t sa r ec o n f o u n d e db y
the fact that seasonal influenza replicated less efficiently
in the ferret lung compared to pdmH1N1 and clearly
lower levels of infection will be associated with lower
induction of host responses. Thus, data from animal stu-
dies cannot differentiate whether the observed effects
were due to intrinsic differences in host responses
induced by the viruses or whether they reflect the viral
replication competence in particular tissues in the
experimental animal model used. Our data arises from a
single-cycle synchronous infection of cells with an
e q u i v a l e n tv i r u sd o s ea n di st h e r e f o r em o r er e l e v a n tt o
investigate the host responses that are driven by intrin-
sic differences between the two H1N1 viruses. It is also
noteworthy that although seasonal influenza H1N1
replicated less efficiently than pdmH1N1 in ferret lung
in vivo, the two viruses replicate comparably in human
type I alveolar epithelial cells and in ex vivo lung cul-
tures [3]. Arguably, the ex vivo lung data showing com-
parable viral tropism and replication competence with
seasonal H1N1 and pdmH1N1 reflects more closely the
epidemiology of the pandemic where pdmH1N1 disease
severity was in fact comparable or milder than that sea-
sonal influenza. If the differences in disease severity
observed following experimental infection of ferrets was
a true reflection of human disease, it would be expected
that pdmH1N1 would be markedly more severe in
humans than it appears to be. These observations in
fact highlight the relevance of using primary and ex vivo
human cell culture data to complement data from
experimental animals.
Conclusions
In this study, we compared the host response to seasonal
and pandemic H1N1 influenza virus in a relevant human
respiratory cell model, the primary human type I-like
epithelial cells that are a primary target in the lung that
may lead to primary viral pneumonia [24,25], including
infection with the recently identified pdmH1N1 virus [3,8].
We conclude that both seasonal H1N1 and pdmH1N1
trigger similar host IFN-related antiviral responses. Type
III IFNs, were more prominently induced by both
viruses when compared with type I IFNs. This highlights
the significance of type III IFN signalling in the patho-
genesis of both pdmH1N1 and seasonal H1N1 viruses.
In agreement with our other recent findings, we
observed that the cytokine and overall host response
profile triggered by both viruses were similar [3,26] and
that pdmH1N1 does not produce the cytokine dysregu-
lation as seen in H5N1 infection. The difference
between the pandemic and seasonal H1N1 viruses lay in
their ability to potentially alter host transcriptional and
translational responses. Down-regulation of zinc finger
proteins and small nucleolar RNAs - possible viral tran-
scriptional suppressors and eukaryotic translation initia-
tion factors, respectively - may facilitate the efficient
replication of seasonal H1N1 influenza virus in the host.
Lacking suppression via these mechanisms suggests
pdmH1N1 virus may be relatively less adapted for repli-
cation in human type I-like alveolar epithelial cells.
We demonstrate differences in regulation of ten zinc
finger proteins and seven small nucleolar RNAs in host
responses to pdmH1N1 and seasonal H1N1 influenza
virus. The role of these proteins in influenza pathogen-
esis merits further investigation.
Additional material
Additional file 1: Summary of gene expression in response to
influenza A virus infection. Fold change of gene expression in
response to pdmH1N1 and seasonal H1N1 at 8 h post-infection time in
human type I-like alveolar epithelial cells that showed significant
difference (p < 0.05, with Benjamini-Hochberg multiple testing correction
and fold change ≥ 1.5) in expression level compared to mock infected
cells were shown. The “-” and no sign before the number indicates the
down- and up-regulation of the gene respectively in influenza A infected
cells compared to mock. HGNC Gene Symbol is HUGO Gene
Nomenclature Committee approved gene symbol. *Ratio [pdmH1N1]/
[seasonal H1N1] indicates the fold change of gene expression in
response to pdmH1N1 compared to seasonal H1N1 infection at 8 h
post-infection time.
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